INDSWFTLABPharmaceuticals
Ind Swift Laboratories Ltd — PE Ratio & Valuation Analysis
₹131.43
+0.97%
Current P/E26.57xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E1.5x1671.3% above avg
✅
16.4% Discount to Industry
INDSWFTLAB P/E 26.57x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹71.24 | ₹109 | 1.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Ind Swift Laboratories Ltd Valuation
Ind Swift Laboratories Ltd (INDSWFTLAB) currently trades at 26.57x earnings. The Pharmaceuticals sector average PE is 31.77x. INDSWFTLAB is trading at a discount to peers — may indicate relative value. Historically, INDSWFTLAB has traded at an average PE of 1.5x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
0.18%
Dividend Yield
0.00%
More on Ind Swift Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.